Download PDF
Thromb Haemost 2001; 86(02): 714-715
DOI: 10.1055/s-0037-1616122
Letters to the Editor
Schattauer GmbH

No Increased Risk of Venous Thrombosis in Women Taking Tranexamic Acid

Erik Berntorp
1   Department for Coagulation Disorders, Lund University, Malmö University Hospital, Malmö, Sweden
,
Christina Follrud
1   Department for Coagulation Disorders, Lund University, Malmö University Hospital, Malmö, Sweden
,
Stefan Lethagen
1   Department for Coagulation Disorders, Lund University, Malmö University Hospital, Malmö, Sweden
› Author Affiliations
Further Information

Publication History

Received 22 January 2001

Accepted after resubmission 27 February 2001

Publication Date:
12 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Ogston D. Antifibrinolytic drugs; chemistry, pharmacology and clinical usage. John Wiley & Sons; 1984
    Google Scholar
  • 2 Reynolds JEF. (ed). Martindale; The extra pharmacopoeia. London: Royal Pharmaceutical Society; 1996
    Google Scholar
  • 3 Dunn CJ, Goa KL. Tranexamic acid. A review of its use in surgery and other indications. Drugs 1999; 57 (Suppl. 06) 1005-32.
    CrossrefPubMedGoogle Scholar
  • 4 Royal College of Obstetricians and Gynaecologists.. The initial management of menorrhagia. Evidence-based clinical guidelines No. 1. RCOG Press; 1998. pp 1-43.
    Google Scholar
  • 5 Cooke I, Lethaby A, Farquhar C. Antifibrinolytics for heavy menstrual bleeding (Cochrane Review). In: The Cochrane Library. Issue 3 2000. Oxford: Update Software.
    Google Scholar
  • 6 Statistisk årsbok för Sverige 2000. Statistiska centralbyrån 2000; 86: 59.
    PubMedGoogle Scholar
  • 7 National Corporation of Pharmacies in Sweden. 2000
    PubMedGoogle Scholar